JAK Inhibitors for Crohn's Disease: A Systematic Review and Dose-Response Network Meta-Analysis of Efficacy and Safety. [PDF]
Qtaishat FA +12 more
europepmc +1 more source
First Reported Case of Upadacitinib-Associated Cytomegalovirus Viremia and Suspected Pneumonitis in Ulcerative Colitis. [PDF]
Javier-Rojas WJ +6 more
europepmc +1 more source
Janus Kinase Inhibitors for Treatment of Palmoplantar Pustulosis, Generalized Pustular Psoriasis, and Palmoplantar Pustular Psoriasis: A Systematic Review of the Literature. [PDF]
Ansari MS +5 more
europepmc +1 more source
Updated review of Janus kinase inhibitors for the management of inflammatory bowel disease. [PDF]
Malakar S, Giri S, Jena A, Nath P.
europepmc +1 more source
Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series. [PDF]
Alajroush W +5 more
europepmc +1 more source
Upadacitinib for the Treatment of Cutaneous Crohn's Disease Presenting as Lymphangioma Circumscriptum. [PDF]
Gerstein B +6 more
europepmc +1 more source
Cutaneous and erosive oral lichen planus treated with upadacitinib. [PDF]
Nwogu O +4 more
europepmc +1 more source
Alopecia Areata - Effects of Treatment with Upadacitinib - Two Case Reports. [PDF]
Młyńska J +3 more
europepmc +1 more source
Refractory oral and cutaneous lichen planus successfully treated with upadacitinib. [PDF]
Riekhof I, Reed A, Pham A.
europepmc +1 more source
Upadacitinib for refractory Behcet's syndrome: a multi-centre, single-arm trial. [PDF]
Li J +19 more
europepmc +1 more source

